Penumbra up 12% on Boston Scientific’s $14.5B buyout



Shares of medtech firm Penumbra, Inc. climbed by over 12% on Thursday after the announcement that it reached an agreement to be acquired by Boston Scientific in a $14.5 billion cash-and-stock deal.The…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento